SecSonar.com

Aclarion, Inc. (ACON)

Aclarion, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Aclarion, Inc. (ACON) is a Medical - Healthcare Information Services company based in US with a market capitalization of $1.7M. Revenue grew 65.6% year-over-year and free cash flow was negative at -$7.2M. This page tracks ACON's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 5 employees · IPO Apr 22, 2022

Valuation

Valuation & price

$3.21 · as of May 23, 2026 · -66.9% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

0.00

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$8.95$5.72$2.49Jul 25Dec 25Jul 26Jul 7, 25$7.75Jul 9, 25$7.32Jul 11, 25$7.20Jul 15, 25$7.34Jul 17, 25$7.41Jul 21, 25$7.32Jul 23, 25$7.43Jul 25, 25$7.47Jul 29, 25$7.70Jul 31, 25$6.95Aug 4, 25$7.00Aug 6, 25$7.65Aug 11, 25$7.29Aug 13, 25$7.09Aug 15, 25$7.32Aug 19, 25$7.02Aug 21, 25$7.27Aug 25, 25$7.30Aug 27, 25$7.05Aug 29, 25$7.17Sep 3, 25$7.20Sep 5, 25$7.15Sep 9, 25$7.10Sep 11, 25$7.45Sep 16, 25$7.67Sep 18, 25$8.20Sep 22, 25$8.89Sep 24, 25$7.70Sep 26, 25$7.62Sep 30, 25$7.50Oct 2, 25$7.48Oct 6, 25$7.65Oct 8, 25$8.91Oct 10, 25$8.60Oct 14, 25$8.95Oct 16, 25$8.70Oct 21, 25$7.84Oct 23, 25$7.62Oct 27, 25$7.65Oct 29, 25$7.88Oct 31, 25$7.76Nov 4, 25$7.50Nov 6, 25$7.51Nov 10, 25$7.24Nov 12, 25$6.90Nov 14, 25$6.16Nov 18, 25$6.11Nov 20, 25$6.12Nov 25, 25$6.15Nov 28, 25$6.26Dec 2, 25$7.17Dec 4, 25$6.95Dec 8, 25$5.88Dec 10, 25$6.76Dec 12, 25$6.44Dec 16, 25$6.04Dec 18, 25$6.34Dec 22, 25$6.20Dec 24, 25$5.88Dec 29, 25$4.94Jan 2, 26$4.98Jan 6, 26$5.37Jan 8, 26$8.17Jan 12, 26$4.51Jan 14, 26$4.18Jan 16, 26$3.79Jan 21, 26$3.85Jan 23, 26$3.80Jan 27, 26$3.64Jan 29, 26$3.62Feb 2, 26$2.88Feb 4, 26$2.70Feb 9, 26$2.76Feb 11, 26$2.71Feb 13, 26$2.58Feb 18, 26$2.49Feb 20, 26$2.54Feb 24, 26$2.52Feb 26, 26$2.68Mar 2, 26$2.86Mar 4, 26$3.10Mar 6, 26$3.27Mar 10, 26$3.28Mar 12, 26$3.33Mar 17, 26$3.24Mar 19, 26$3.26Mar 23, 26$3.12Mar 25, 26$3.23Mar 27, 26$3.06Mar 31, 26$3.27Apr 2, 26$3.57Apr 7, 26$3.56Apr 9, 26$3.50Apr 13, 26$3.21Apr 15, 26$3.20Apr 17, 26$3.39Apr 22, 26$3.73Apr 24, 26$3.30Apr 28, 26$3.37Apr 30, 26$3.32May 4, 26$3.31May 6, 26$3.28May 8, 26$3.19May 12, 26$3.15May 14, 26$3.22May 18, 26$3.20May 20, 26$3.19May 22, 26$3.21May 28, 26$3.15Jun 1, 26$3.37Jun 3, 26$3.49Jun 5, 26$3.57Jun 9, 26$3.26Jun 11, 26$3.21Jun 15, 26$3.03Jun 17, 26$3.11Jun 22, 26$3.04Jun 24, 26$2.74Jun 26, 26$2.85Jul 2, 26$3.09
$2.3652-week range$9.69
Loading valuation history…

Fundamentals

Key fundamentals

$1.7M

Market cap

65.6%

Revenue growth (YoY)

-291.3%

Gross margin

-$7.2M

Free cash flow (USD)

-$12M

Net debt

Net cash position

56329.2%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2019 → 2025

FY 2019$26.9KFY 2020$48.7KFY 2021$60.3KFY 2022$60.4KFY 2023$75.4KFY 2024$45.7KFY 2025$75.7K
$26.9K$75.7K

Free cash flow by year

2019 → 2025

FY 2019$-4.4MFY 2020$-2.0MFY 2021$-2.3MFY 2022$-5.2MFY 2023$-3.8MFY 2024$-5.6MFY 2025$-7.2M
-$4.4M-$7.2M

Gross margin by year

2021 → 2025

FY 2021-14.7%FY 2022-8.0%FY 2023-0.4%FY 2024-183.8%FY 2025-291.3%
-14.7%-291.3%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

4

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last reported: May 21, 2026 (EPS $-1.34)

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventAnnual Meeting ResultsJun 4, 2026Filing
  • Quarterly report10-Q FiledMay 13, 2026Filing
  • Insider buyInsider Buy $8KNeal David K · Director · $7.8KMay 12, 2026Filing
  • Insider buyInsider Buy $18KBreidbart Scott · Director · $18KMay 12, 2026Filing
  • Insider buyInsider Buy $20KNess Brent · Director, Chief Executive Officer · $20KMay 11, 2026Filing
  • Insider buyInsider Buy $5KWesemann William · Director · $5.2KMay 8, 2026Filing
  • 8-K eventShare Repurchase ProgramApr 22, 2026Filing

Questions

Frequently asked questions

What is Aclarion, Inc.'s market cap?

Aclarion, Inc. (ACON) has a market capitalization of $1.7M.

What is ACON's P/E ratio?

A meaningful P/E ratio is not available for ACON — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is ACON's price-to-book (P/B) ratio?

ACON trades at 0.00 times book value per share.

When did Aclarion, Inc. last report earnings?

ACON last reported earnings on May 21, 2026; the next date is not yet scheduled.

Are insiders buying ACON stock?

Yes — SEC Form 4 filings show 4 open-market insider buys and 0 sells at Aclarion, Inc. in the last 90 days.

Same arena

Related companies in Medical - Healthcare Information Services

ZCMD

Zhongchao Inc.

$595.6K

HCTI

Healthcare Triangle, Inc.

$2.9M

VSEE

VSee Health, Inc.

$3.1M

MGRX

Mangoceuticals, Inc.

$4.8M

SCNX

Scienture Holdings, Inc.

$6.4M

BFRG

Bullfrog AI Holdings, Inc. Common Stock

$7.8M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.